T 1150/15 (Integrase inhibitors/SHIONOGI) of 11.10.2017

European Case Law Identifier: ECLI:EP:BA:2017:T115015.20171011
Date of decision: 11 October 2017
Case number: T 1150/15
Petition for review of: -
Application number: 02749384.0
IPC class: A61K 31/50 A61K 31/4015 C07D 407/06 A61K 31/4178 A61K 31/43 C07D 207/38 C07D 401/04 C07D 417/06 A61K 31/4025 C07D 413/06 A61K 31/4155 C07D 413/04 C07D 403/04 A61K 31/366 C07D 405/06 C07D 403/06 A61K 31/42 C07D 409/06 C07D 405/04 A61K 31/44 A61P 31/18
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: ANTIVIRAL AGENT
Applicant name: SHIONOGI & CO., LTD.
Opponent name: Merck & Co., Inc.
Board: 3.3.01
Headnote: -
Relevant legal provisions: European Patent Convention Art 123(2)
Keywords: Amendments - extension beyond the content of the application as filed (yes)
Catchword: -
Cited cases: G 0002/10 T 0615/95 T 0823/96 T 0068/99 T 1357/06 T 0812/08 T 1420/11 T 1708/11 T 1853/13
Citing cases: -

Order

For these reasons it is decided that:

1. The decision is set aside.

2. The patent is revoked.